Antipodes Partners’s Certara CERT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Buy
83,677
+22,545
+37% +$127K 0.01% 88
2026
Q1
$348K Buy
61,132
+58,942
+2,691% +$450K 0.01% 85
2025
Q4
$19.3K Sell
2,190
-10,095
-82% -$104K ﹤0.01% 123
2025
Q3
$150K Buy
12,285
+5,620
+84% +$61.5K ﹤0.01% 81
2025
Q2
$78K Buy
6,665
+1,223
+22% +$14.5K ﹤0.01% 78
2025
Q1
$53.9K Hold
5,442
﹤0.01% 80
2024
Q4
$58K Buy
5,442
+3,656
+205% +$39.7K ﹤0.01% 69
2024
Q3
$20.9K Buy
+1,786
New +$23.6K ﹤0.01% 81

Other funds holding CERT

Antipodes Partners's CERT Position: Q2 2026 in Review

Antipodes Partners increased its Certara (CERT) stake by 37% in Q2 2026, buying an estimated $127K and bringing the position to 83,677 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #88.

Antipodes Partners first reported a position in CERT in Q3 2024 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold CERT as of Q2 2026.

  • Antipodes Partners held 83,677 shares of Certara worth $548K as of Q2 2026.
  • Antipodes Partners bought 22,545 Certara shares in Q2 2026, an estimated $127K.
  • Certara made up 0.01% of Antipodes Partners's portfolio in Q2 2026, its #88 holding.
  • Antipodes Partners first reported a position in Certara in Q3 2024 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held Certara as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.